Войдите в систему

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing spindle formation in dividing cells, activating kinase activity, to regulate expression of B-cell lymphoma 2 (BCL-2), or affecting dynein interactions. These changes ultimately lead to necrosis or apoptosis of cells.

Different binding sites for microtubule destabilizing drugs have been identified—colchicine binding site, which is also used by drugs like podophyllotoxin and combretastatin. Vinca alkaloid binding site where drugs like vinblastin, vincristine, dolastatin 10, and dolastatin 15 can bind.

Vinca alkaloids, vincristine, and vinblastine owing to their ability to destabilize or prevent polymerization of microtubules have been widely used as anticancer drugs against diseases like breast cancer, lymphomas, and sarcomas. In 1958, Vinblastin was first isolated from Catharanthus roseus, and it was first approved for a drug trial in 1994 against breast cancer. Vinorelbine, another vinca alkaloid, shows suppression of angiogenesis in tumor cells. It further prevents nutrient and oxygen supply from reaching the tumor cells, leading to starvation and ultimately apoptosis. Maytansinoids and auristatins, another group of microtubule destabilizing drugs, have different binding sites close to the vinca binding sites on the microtubules, where they promote depolymerization. These drugs help prevent cell division by disrupting the spindle apparatus leading to cell arrest.

Теги
MicrotubulesMicrotubule Targeting AgentsMTAsMicrotubule Destabilizing DrugsVinca AlkaloidsVincristineVinblastineColchicineBinding SitesB cell Lymphoma 2NecrosisApoptosisAnticancer DrugsBreast CancerLymphomasSarcomasAngiogenesisMaytansinoidsAuristatins

Из главы 26:

article

Now Playing

26.13 : Drugs that Destabilize Microtubules

The Cytoskeleton II: Microtubules and Intermediate Filaments

1.9K Просмотры

article

26.1 : Микротрубочки

The Cytoskeleton II: Microtubules and Intermediate Filaments

6.9K Просмотры

article

26.2 : Нестабильность микротрубочек

The Cytoskeleton II: Microtubules and Intermediate Filaments

3.3K Просмотры

article

26.3 : Образование микротрубочек

The Cytoskeleton II: Microtubules and Intermediate Filaments

5.3K Просмотры

article

26.4 : Белки, ассоциированные с микротрубочками (MAP)

The Cytoskeleton II: Microtubules and Intermediate Filaments

3.9K Просмотры

article

26.5 : Дестабилизация микротрубочек

The Cytoskeleton II: Microtubules and Intermediate Filaments

2.5K Просмотры

article

26.6 : Моторные белки, ассоциированные с микротрубочками

The Cytoskeleton II: Microtubules and Intermediate Filaments

7.4K Просмотры

article

26.7 : Движение органелл и везикул

The Cytoskeleton II: Microtubules and Intermediate Filaments

4.2K Просмотры

article

26.8 : Сборка сложных структур микротрубочек

The Cytoskeleton II: Microtubules and Intermediate Filaments

1.8K Просмотры

article

26.9 : Микротрубочки в подвижности клеток

The Cytoskeleton II: Microtubules and Intermediate Filaments

3.1K Просмотры

article

26.10 : Механизм движения ресничек

The Cytoskeleton II: Microtubules and Intermediate Filaments

3.5K Просмотры

article

26.11 : Микротрубочки в сигнализации

The Cytoskeleton II: Microtubules and Intermediate Filaments

1.7K Просмотры

article

26.12 : Препараты, стабилизирующие микротрубочки

The Cytoskeleton II: Microtubules and Intermediate Filaments

1.9K Просмотры

article

26.14 : Структура промежуточных нитей

The Cytoskeleton II: Microtubules and Intermediate Filaments

3.7K Просмотры

article

26.15 : Типы промежуточных нитей накаливания

The Cytoskeleton II: Microtubules and Intermediate Filaments

3.5K Просмотры

See More

JoVE Logo

Исследования

Образование

О JoVE

Авторские права © 2025 MyJoVE Corporation. Все права защищены